Summary. Thirty-nine patients (14 non-diabetics, 8 chemical diabetics, and 17 overt diabetics) with circulating islet cell antibodies (ICA) were studied. Insulin and glucagon secretion after oral (100 g) and intravenous glucose loading (200 mg/kg bolus injection followed by an infusion of 20 mg/min over 60 min) and arginine infusion (25 g over 30 minutes) were evaluated in these patients and in non diabetic and diabetic ICA-negative controls. In the non-diabetic groups with or without ICA, insulin and glucagon responses to glucose were similar. Moreover, in ICA positive patients the response of these hormones to arginine infusion was reduced. Similar alterations in insulin and glucagon secretion were observed in the ICA positive and negative patients with chemical or overt diabetes. In particular, fasting hyperglucagonaemia and glucagon hyperresponse to arginine are associated with a lack of insulin secretion in the patients with overt diabetes. Hormonal differences between diabetics with and without ICA could not be detected.
sociated polyendocrine autoimmune disorders [2, 17] . These antibodies were later observed in many cases of juvenile diabetes of recent onset, not associated with endocrinopathies [13, 16] . ICA have also been reported in a small percentage of both maturity-onset and chemical diabetics and in some non-diabetics affected with one or more autoimmune disorders [6, 13] .
The presence of specific islet-cell autoimmune activity, as suggested by circulating ICA, might play an important role in the development of the diabetic cell alteration. It has not yet been demonstrated if ICA are associated with or are responsible for the anatomical and functional damage of islet cells.
ICA have been demonstrated not only in diabetics but also in subjects with normal glucose tolerance [6] ; in some cases the detection of ICA preceded the development of diabetes [2, 6] .
The purpose of this work was twofold: to determine if ICA are always associated with functional islet-cell damage and if, in ICA positive diabetics, the lack of insulin secretion is associated with reduced glucagon production. The hypothesized reduction in glucagon secretion might be due to a coexisting involvement of both beta and alpha cells. This was suggested by Bottazzo et al. [2] on the basis of the immuno-fluorescent pattern produced by ICA, which seem to react against all the islet cells.
Materials and Methods
Thirty-nine patients with ICA were studied. These subjects were selected from a large group originally compiled for an epidemiological study [7] and successively divided into 3 sub-groups on the basis of their metabolic status, according to Fajans The principal clinical and metabolic data of these patients are presented in Table 1 .
A control group of 31 subjects, in whom ICA were not detected, was also studied. These were similarly divided into 3 groups on the basis of their glucose tolerance. Group 1:15 subjects with normal glucose tolerance, Group 2:8 subjects with chemical diabetes, and Group 3:8 subjects with overt diabetes (Table 2) .
Both patients and controls were studied during a hospital stay or through our out-patient clinic and were asked to follow a balanced diet containing at least 250 g/carbohydrate daily for at least 2 weeks prior to testing. Use of insulin and antidiabetic oral drugs was interrupted 24 hours before testing.
The following tests were carried out in the ICA positive patients and in the ICA negative controls: -Oral Glucose Tolerance Test: (100 g) (not carried out in the patients with overt diabetes). Blood samples were collected at 0, 30, 60, 90, 120, 180, and 240 minutes. M. [2] . Fresh human pancreas was used as the tissue substrate for these experiments. All sera was also tested for antibodies to thyroglobulin, thyroid microsomal, adrenal and to parietal cells [24] . Sera was initially tested undiluted on the pancreas for 30 minutes and at 1 : 5 on other substrates. Titres were established by repeating the sandwich test with serial dilutions.
During arginine tests the area of the single variable above basal values was calculated. Statistical analysis was carried out using Student's "t" test. 
Results

Plasma Glucose
After oral glucose ( Fig. 1 ) a mean flat glycaemic curve was observed in ICA positive non-diabetics. Glucose values were significantly lower at 30, 60, and 90 minutes with respect to the ICA negative patients. Glucose values were similar in the ICA positive and negative chemical diabetics.
No significant difference (Fig. 2) was observed between ICA positive and negative subjects during the maximal hyperglycaemic phase of intravenous glucose infusion. Only at 90 minutes were significantly lower values observed in the ICA positive non-diabetics.
Glucose increase was significantly reduced at 15, 30, 45, and 60 minutes of arginine infusion in ICA positive non-diabetics with respect to the control group (Fig. 3) . No significant differences were observed during arginine infusion between the chemical diabetic groups or between the overt diabetic groups.
Plasma Insulin
Insulin fasting levels were similar in the patient and control groups. No significant difference was observed in insulin response to oral (Fig. 1 ) and intravenous glucose (Fig. 2) between ICA positive and negative subjects. Non-diabetic ICA positive patients, in fact, presented a normal early insulin secretion. In ICA positive and negative chemical diabetics insulin secretion was reduced and delayed (Fig. 2) .
During arginine infusion (Fig. 3) insulin response was significantly reduced at 30, 45, and 60 minutes in the non-diabetic ICA positive patients with respect to the controls. Insulin secretion, calculated as the area, was also significantly reduced (p < 0.05). Progressive reduction in insulin secretion was present in chemical and in overt diabetes both in ICA positive and negative subjects. Insulin area measurements were consistent with this finding.
Plasma Glucagon
No significant difference in fasting levels was observed between respective ICA positive and negative subgroups. In both groups the deterioration of the metabolic condition was associated with an increase in glucagon levels (Tables 1 and 2 ). During hyperglycaemia following intravenous glucose infusion, glucagon behaviour was similar in ICA positive and negative subjects. A reduction in glucagon levels was observed in the non-diabetics. No reduction was reported in either of the groups with chemical diabetes in whom glucagon levels were never less than basal values (Fig. 2) .
Glucagon response to arginine was slightly reduced in the ICA positive non-diabetics (p < 0.05 at 45 min) with respect to the controls (Fig. 3) . No significant difference, on the other hand, was observed in the response of glucagon and of its respective area in the groups with chemical or overt diabetes (Fig. 3) . 
Discussion
In non-diabetics the presence of circulating ICA does not seem to be associated with diabetic-like alterations of beta-cell function. In fact, the 14 patients with ICA and normal glucose tolerance showed normal insulin secretion after oral or intravenous glucose administration. The finding of specific autoantibodies in the absence of overt deficiency of the target gland is not unusual in endocrine autoimmunity (thyroid or adrenal), and the discovery of autoantibodies may antedate the onset of endocrine impairment. ICA, therefore, might precede the onset of an anatomical and/or functional islet-cell alteration of the diabetic type, as observed in some cases [2, 6] . Only a pro-A. Tiengo et al.: [3 and ct Cell Function in Islet Cell Autoimmunity spective study will be able to clarify whether the presence of ICA should be considered a marker of a prediabetic condition, as suggested recently by Irvine [14] .
As regards alpha-cell function, normal fasting glucagon levels, normal suppression by hyperglycaemia, and reduced glucagon secretion during arginine infusion were observed in the ICA positive non-diabetics. Reduced glucagon response cannot be explained by alpha-cell damage due to a specific autoimmune process since ICA positive diabetics showed fasting and arginine-induced hyperglucagonaemia. In ICA positive non-diabetics, reduced alpha cell reactivity might partially explain the absence of arginine-induced hyperglycaemia~ It would seem that the first phase of islet cell autoaggressirn is associated with an alteration in the responsitivity of beta and alpha cell membrane receptors to arginine. It is more difficult to explain the flat glycaemic curve after oral glucose observed in ICA positive non-diabetics. Nevertheless, "flat curves" at OGTT are reported in 25% of the general population with normal glucose tolerance [22] and may be observed more frequently in polyendocrine patients with adrenal or thyroid involvement, as in the majority of our non-diabetic subjects with ICA.
Neither overt nor chemical "autoimmune" diabetes show beta or alpha cell alterations different from those generally reported in diabetes mellitus. In fact, in our ICA positive patients the reduction of insulin secretion was in proportion to the rise in fasting glucagon levels and to the increase in alpha cell response to arginine also observed in ICA negative overt diabetics. "Autoimmune diabetes", therefore, cannot be classified among the diabetic conditions characterized by both beta and alpha cell anatomic-functional damage, such as diabetes secondary to pancreatectomy, chronic pancreatitis, or haemochromatosis [1, 23] .
It has been observed that the ICA immunofluorescent pattern involves all of the islet cells. Moreover, diffuse anatomical alterations of the islet cells have been reported in experimental autoimmune insulitis [5] . It is also known that endocrine autoimmunity may be directed against more than one type of target-cells. These considerations seem to suggest that "autoimmune" diabetes could lead to a reduction in both insulin and glucagon production [2] . This hypothesis was not confirmed by fasting hyperglucagonaemia, lack of glucagon suppression during glucose infusion and arginine induced hyperglucagonaemia, common features of "genetic" diabetes [18, 26] or experimental diabetes obtained with anti-insulin antibodies, alloxan or streptozoto- cin [15, 19] . It is probable, therefore, that ICA are specific only for a beta-cell antigen, while in the immunofluorescent test they crossreact to antigenic components of other islet cells. However, specific alpha-cell autoantibodies do really exist and have been demonstrated. In some diabetics alpha cell antibodies may be associated with tCA [3] . It is only in the latter condition that a depression of alpha cell function might be associated with a diabetic condition.
